Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans

• Published in: Journal of applied physiology (1985) Vol. 108; no. 6; pp. 1487 - 1496
• Main Authors: Timmons, James A., Knudsen, Steen, Rankinen, Tuomo, Koch, Lauren G., Sarzynski, Mark, Jensen, Thomas, Keller, Pernille, Scheele, Camilla, Vollaard, Niels B. J., Nielsen, Søren, Åkerström, Thorbjörn, MacDougald, Ormond A., Jansson, Eva, Greenhaff, Paul L., Tarnopolsky, Mark A., van Loon, Luc J. C., Pedersen, Bente K., Sundberg, Carl Johan, Wahlestedt, Claes, Britton, Steven L., Bouchard, Claude
• Format: Journal Article
• Language: English
• Published: Bethesda, MD American Physiological Society 01.06.2010
• Subjects: Biological and medical sciences; Biomarkers; Deoxyribonucleic acid; DNA; endurance training; Exercise; Family studies; Fundamental and applied biological sciences. Psychology; Gene expression; Gene mapping; Genetic diversity; Genetic variance; genotype; Genotype & phenotype; Heterogeneity; Humans; Male; Mortality; Muscle Proteins - genetics; NATURAL SCIENCES; NATURVETENSKAP; Oxygen consumption; Oxygen Consumption - genetics; personalized medicine; Phenotype; Physical Endurance - genetics; Physical Exertion - physiology; Physical Fitness - physiology; Physical training; Polymorphism; Polymorphism, Single Nucleotide - genetics; Regression analysis; Ribonucleic acid; Risk factors; RNA; Young Adult; Physical exercise; Human; Vertebrata; Physical training; Mammalia; Classification; endurance training; Genotype; Endurance; personalized medicine
• ISSN: 8750-7587; 1522-1601; 1522-1601
• DOI: 10.1152/japplphysiol.01295.2009

A low maximal oxygen consumption (V̇o 2max ) is a strong risk factor for premature mortality. Supervised endurance exercise training increases V̇o 2max with a very wide range of effectiveness in humans. Discovering the DNA variants that contribute to this heterogeneity typically requires substantial sample sizes. In the present study, we first use RNA expression profiling to produce a molecular classifier that predicts V̇o 2max training response. We then hypothesized that the classifier genes would harbor DNA variants that contributed to the heterogeneous V̇o 2max response. Two independent preintervention RNA expression data sets were generated ( n = 41 gene chips) from subjects that underwent supervised endurance training: one identified and the second blindly validated an RNA expression signature that predicted change in V̇o 2max (“predictor” genes). The HERITAGE Family Study ( n = 473) was used for genotyping. We discovered a 29-RNA signature that predicted V̇o 2max training response on a continuous scale; these genes contained ∼6 new single-nucleotide polymorphisms associated with gains in V̇o 2max in the HERITAGE Family Study. Three of four novel candidate genes from the HERITAGE Family Study were confirmed as RNA predictor genes (i.e., “reciprocal” RNA validation of a quantitative trait locus genotype), enhancing the performance of the 29-RNA-based predictor. Notably, RNA abundance for the predictor genes was unchanged by exercise training, supporting the idea that expression was preset by genetic variation. Regression analysis yielded a model where 11 single-nucleotide polymorphisms explained 23% of the variance in gains in V̇o 2max , corresponding to ∼50% of the estimated genetic variance for V̇o 2max . In conclusion, combining RNA profiling with single-gene DNA marker association analysis yields a strongly validated molecular predictor with meaningful explanatory power. V̇o 2max responses to endurance training can be predicted by measuring a ∼30-gene RNA expression signature in muscle prior to training. The general approach taken could accelerate the discovery of genetic biomarkers, sufficiently discrete for diagnostic purposes, for a range of physiological and pharmacological phenotypes in humans.